Health: Leading Alzheimer’s theory undermined: Did tampering waste 16 years of research?

Predictions of the death of the handshake were premature

  Predictions of the death of the handshake were premature The handshake's potential demise was predicted in the early days of the pandemic, but it has proven to be just too resilient to fade away. "There's the science. I think there's the fact that it's not only an ingrained habit for a lot of people, but there is also no good replacement," said Andrew Molinsky, a professor of organizational behaviour at Brandeis University's International Business School in Boston. Molinsky said that among the "portfolio of greetings," which includes the first bump, the elbow, the smile and wave, "the market share has been dominated and still is dominated by the handshake.

Hundreds of millions of dollars and years of research across an entire field may have been wasted due to potentially falsified data that helped lay the foundation for the leading hypothesis of what causes Alzheimer's disease.

In this file photo, a doctor looks at PET brain scans. © AP Photo/Matt York, File In this file photo, a doctor looks at PET brain scans.

The allegations centre around a landmark 2006 study — a paper which has been cited nearly 2,300 times — whose findings identify a protein called amyloid beta as a cause of Alzheimer's. Since then, the hypothesis that sticky deposits of amyloid beta form plaques in the brain that slow cognition has dominated Alzheimer's research and treatment development.

Alana 'Honey Boo Boo' Thompson Is Considering Weight Loss Surgery — but Should Teens Get it? A Doctor Explains

  Alana 'Honey Boo Boo' Thompson Is Considering Weight Loss Surgery — but Should Teens Get it? A Doctor Explains Dr. Christopher McGowan explains to PEOPLE what an endoscopic sleeve gastroplasty (ESG) is and whether the procedure is safe for children and teensEarlier this week, Alana Thompson revealed she is considering getting a suture sculpt endoscopic sleeve — typically referred to as an endoscopic sleeve gastroplasty (ESG) — after unsuccessfully trying to lose the weight by herself over the past year.

But a six-month investigation by Science magazine has revealed that the data backing up this influential study may have been doctored, potentially leading scientists down the wrong road for 16 years.

Read more:

‘Young people should not drink’: World study challenges alcohol guidelines

The controversial research was authored by Sylvain Lesné from the University of Minnesota, who at the time was a new PhD student working under the highly-regarded Alzheimer's researcher Karen Ashe.

Lesné's paper purported to show that a specific subtype of amyloid beta (Aβ*56) caused dementia in rats and was hailed as a major breakthrough — bringing awards, funding and notoriety to its authors, but also breathing new life into the amyloid beta theory.

Trader Joe's Just Added These 13 Late-Summer Foods to Stores

  Trader Joe's Just Added These 13 Late-Summer Foods to Stores There are so many limited edition crowd-pleasers this time around.

In the U.S., Science found that the National Institute of Health (NIH) went from directing zero dollars for amyloid-related Alzheimer's research in 2006, when Lesné's research was published, to US$287 million in 2021.

Read more:

Canadian health officials to hold monkeypox update after WHO declares emergency

A handful of scientists doubted the results of Lesné's research but it wasn't until 2021 when Matthew Schrag, a neuroscientist and physician from Vanderbilt University, dug deeper and found evidence that Lesné's findings weren't all they appeared to be.

While visiting PubPeer, a website where scientists flag possible errors in peer-reviewed research, Schrag came across postings that questioned the authenticity of some of Lesné's graphs showing amyloid beta concentration levels. The images showed evidence of tampering and duplication, with some results seemingly cut and pasted to appear stronger.

Monkeypox Symptoms Usually Appear Like This, According to an Infectious Disease Expert

  Monkeypox Symptoms Usually Appear Like This, According to an Infectious Disease Expert Monkeypox Symptoms Usually Appear Like This, According to an Infectious Disease ExpertAs an immunologist and allergist at NYU Langone and an Assistant professor of medicine in the division of infectious disease and immunology, I observe a rise in cases globally and want to make sure that everyone is aware of the symptoms and risks. It's important to know when you should seek treatment or know when you have been exposed to obtain a vaccine.

Schrag launched his own investigation into Lesné's work and found evidence of image tampering in some 20 papers.

Read more:

Georgia woman left paralyzed, in ICU after chiropractor visit, family says

In a whistleblower report to NIH, Schrag wrote that his findings represent only "a fraction of the anomalies easily visible on review of the publicly accessible data."

He added that Lesné's work "not only represents a substantial investment in (NIH) research support, but has been cited … thousands of times and thus has the potential to mislead an entire field of research.”

Nobel laureate Thomas Südhof agrees, saying in an interview with Science that Lesné's paper provided an "important boost" to the amyloid hypothesis at a time when scientists were beginning to direct their attention elsewhere.

"The immediate, obvious damage is wasted NIH funding and wasted thinking in the field because people are using these results as a starting point for their own experiments," the Stanford neuroscientist said.

Read more:

Doctors say health system has ‘collapsed’ as patient surges fuel ER closures

Trust Us When We Say This Will Help You Lose Belly Fat

  Trust Us When We Say This Will Help You Lose Belly Fat There are many different ways that people say you can lose weight, but we wanted to find the best, healthiest, most sustainable way. Read on.The short answer is, yes, there is! To learn more, we talked with a few expert dietitians about eating habits that can help with losing belly fat, also known as visceral fat or abdominal fat. According to Trista Best, MPH, RD, LD at Balance One Supplements and Courtney D'Angelo, MS, RD, author at Go Wellness, the best ways to help you lose belly fat are incorporating regular fiber and getting enough protein into your daily diet.

On July 14 of this year, Nature added a warning to Lesné's 2006 study, writing, "The editors of Nature have been alerted to concerns regarding some of the figures in this paper. Nature is investigating these concerns, and a further editorial response will follow as soon as possible. In the meantime, readers are advised to use caution when using results reported therein."

Lesné so far has not made any public comment on the allegations, but the University of Minnesota says it is investigating the claims.

The Alzheimer Society of Canada (ASC), which has distributed $67 million in grants for Alzheimer's research since its inception, issued a public statement regarding the allegations, saying they are monitoring the situation.

In a statement to Global News, Saskia Sivananthan, chief of research, knowledge transfer and exchange for the ASC wrote, "The recent news of potential research misconduct is serious and requires further inquiry, however, it is important that all dementia research should not be painted with the same broad brush of these allegations given how large and diverse the field of dementia research is."

"There is no doubt that the amyloid beta hypothesis had an impact on the direction of dementia research throughout the world, however, again, it is important to note that amyloid beta is one of a large number of hypotheses that researchers are studying to understand the possible causes of dementia right now," Sivananthan added.

Sure Signs You're Having a Stroke

  Sure Signs You're Having a Stroke There are two types of strokes, and they both cause the same problem, a lack of blood flow in the brain. Read on to ensure your health.

Read more:

Micrometeoroid causes ‘uncorrectable’ damage to James Webb Space Telescope

Gerold Schmitt-Ulms, a University of Toronto professor at the Tanz Centre for Research in Neurodegenerative Disease, echoed their sentiments, saying that while the allegations of misconduct are credible, he's more worried about what implications this has for the loss of public trust in Alzheimer's research.

"It is neither new nor surprising that a small number of individuals in the sciences resort to fraudulent activity because the short-term gain, measured in research funding or career advancement, can be considerable," he wrote to Global News. "Fortunately, in this case, the implications for (Alzheimer's disease) research are minor."

According to Schmitt-Ulms, the direction of Alzheimer's research is unlikely to fundamentally change in light of these allegations because so much is still unknown about the early stages of the disease.

Read more:

New studies say COVID-19 virus originated in Wuhan market in China

"Most research groups in Canada no longer focus on (amyloid beta) but anybody studying (Alzheimer's disease) is well advised to not ignore this molecule either," he said.

Even still, the ASC concedes that Lesné's potential misconduct is worrying, writing that "any potential diversion of money or time is a cause for concern," given that dementia costs the Canadian economy more than $10.4 billion annually.

While it's impossible to know the true losses to Alzheimer's research if Lesné did indeed falsify his data, it's hard to ignore that the only Alzheimer's drug that has come to market in North America is a treatment that targets amyloid beta.

Video: U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 years

Aduhelm, a drug developed by Biogen, recently received approval from the U.S. Food and Drug Administration despite little clinical evidence that it benefits those who suffer from Alzheimer's. The drug was controversially fast-tracked through the approval process in order to further amyloid beta research.

The drug was initially submitted for approval from Health Canada but was withdrawn by the company.

Despite the increased scrutiny on amyloid beta, Schmitt-Ulms hasn't given up on the protein, or drugs that combat it, saying "The door toward (anti-amyloid beta) therapies should not be closed."

"There also exists the possibility that a combination therapy targeting the accumulation of aberrant (amyloid beta) and something else may prove to be effective."

Video: Health Matters: Living with early-onset Alzheimer’s

Queen Elizabeth’s Story Is More Tragic Than People Know .
Queen Elizabeth’s Story Is More Tragic Than People KnowMost of us know her simply as “The Queen,” but she was born Elizabeth Alexandra Mary Windsor on April 21, 1926. At the time of her birth, her paternal grandfather George V was king, and her father was his second son. This meant that she was third in line for the throne—and unlikely to ever come close to it. Well, fate had something different in mind.

See also